SummaryGlobal Market Direct’s pharmaceuticals report, “Enanta Pharmaceuticals, Inc. -Product Pipeline Review - 2012” provides data on the Enanta Pharmaceuticals,Inc.’s research and development focus. The report includes information oncurrent developmental pipeline, complete with latest updates, and features ondiscontinued and dormant projects.This report is built using data and information sourced from Global MarketsDirect’s proprietary databases, Enanta Pharmaceuticals, Inc.’s corporatewebsite, SEC filings, investor presentations and featured press releases, bothfrom Enanta Pharmaceuticals, Inc. and industry-specific third party sources, puttogether by Global Markets Direct’s team.
Scope- Enanta Pharmaceuticals, Inc. - Brief Enanta Pharmaceuticals, Inc. overviewincluding business description, key information and facts, and its locations andsubsidiaries.- Review of current pipeline of Enanta Pharmaceuticals, Inc. human therapeuticdivision.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Reasons to buy- Evaluate Enanta Pharmaceuticals, Inc.’s strategic position with total access todetailed information on its product pipeline.- Assess the growth potential of Enanta Pharmaceuticals, Inc. in its therapy areas offocus.- Identify new drug targets and therapeutic classes in the Enanta Pharmaceuticals,Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in thoseareas.- Exploit in-licensing opportunities by identifying windows of opportunity to fillportfolio gaps.
Table of Contents :List of Tables 4List of Figures 4Enanta Pharmaceuticals, Inc. Snapshot 5Enanta Pharmaceuticals, Inc. Overview 5Key Information 5Key Facts 5Enanta Pharmaceuticals, Inc. – Research and Development Overview 6Key Therapeutic Areas 6Enanta Pharmaceuticals, Inc. – Pipeline Review 8Pipeline Products by Stage of Development 8Pipeline Products – Monotherapy 9Enanta Pharmaceuticals, Inc. – Pipeline Products Glance 10Enanta Pharmaceuticals, Inc. Clinical Stage Pipeline Products 10Phase I Products/Combination Treatment Modalities 10Enanta Pharmaceuticals, Inc. – Early Stage Pipeline Products 11Pre-Clinical Products/Combination Treatment Modalities 11Discovery Products/Combination Treatment Modalities 12Enanta Pharmaceuticals, Inc. – Drug Profiles 13Bicyclolide Antibiotics 13…………….
Please follow link if you want More RelatedReports :Product Pipeline Review – 2012http://www.aarkstore.com/search/viewresults.asp?search=ProductPipeline Review&PubId=&pagenum=1
For More details about above & otherReports plz contact :LavanyaAarkstore.comContact: Marketing team Mob.No.918149852585Email: firstname.lastname@example.org ,email@example.comURL: http://www.aarkstore.comhttp://in.linkedin.com/in/aarkstorehttp://www.facebook.com/aarkstore